There’s no better way to start a new year than building positive momentum. Between great developments on coronary reimbursement to positive real-world data for Reducer, 2024 is off to a shock-worthy start.
Another highlight was the continuous enrollment of patients in our EMPOWER CAD Study — the first prospective clinical study in the interventional space completely dedicated to female patients. Our team also created new resources about optimal sizing for Peripheral IVL, as well as put the final touches on our new manufacturing facility in Costa Rica. Read more about our strong start and get excited about what’s to come in the latest edition of the PulsePoint Newsletter.
Read More
Topics:
Coronary IVL,
Peripheral IVL,
IVL Technology,
Coronary Clinical Data,
Peripheral Conferences,
Peripheral Clinical Data,
SWAV News,
Shockwave C2,
Coronary Conferences,
Shockwave S4,
PulsePoint Newsletter,
Calcium Corner,
Shockwave M5 & Shockwave M5+,
Reimbursement,
Treating Different Ca++ Morphologies,
Female vs. Male Outcomes,
Empower CAD,
Reducer
Get your wetsuits ready because Shockwave's SCAI 2024 lineup will cause some serious waves in Long Beach. Take a look at the hot topics Shockwave has in store for you this year including:
Read More
Topics:
Coronary IVL,
IVL Technology,
Shockwave C2,
Coronary Conferences
Ein aufregendes Jahr 2023 liegt hinter uns mit drei großen Highlights: Verbesserung der Erstattungslage für die koronare IVL in Deutschland, Launch des neuen koronaren IVL C2+ Katheters und die Integration des REDUCERs in die Shockwave Produktpalette!
Read More
In this Cath Lab Digest article, Dr. Yousif Ahmad of Yale School of Medicine, New Haven, Connecticut breaks down the new hospital inpatient and physician reimbursement for Coronary IVL. Dr. Ahmad shares his perspective on how the recently established CPT and DRG codes may impact the utilization of Coronary IVL in the cath lab.
Read More
Topics:
Coronary IVL,
Shockwave C2,
Calcium Corner
Enrollments in the EMPOWER CAD study are picking up pace! Dr Nieves Gonzalo (Hospital Clìnico San Carlos, Madrid), the study’s European lead, recently shared with the medical community the journey of her first patient included in the study.
Read More
Topics:
Coronary IVL,
IVL Technology,
SWAV News,
Shockwave C2
Though sizing 1:1 to the healthy RVD may be a customary approach seen in other devices like traditional balloon angioplasty, Peripheral IVL is an exception to the rule. It's recommended to oversize Peripheral IVL by 10% (a ratio of 1.1:1) to the healthy RVD because it achieves better and sustained wall apposition, which leads to more efficient energy transfer from the IVL device.(1, 2, 3)
Read More
Topics:
Peripheral IVL,
Peripheral Clinical Data
für Patienten mit kalzifizierter pAVK durch periphere Intravaskuläre Lithotripsie (IVL)
Read More
Topics:
Peripheral IVL,
Reimbursement
For patients with calcified PAD with Peripheral Shockwave Intravascular Lithotripsy (IVL)
Read More
Topics:
Peripheral IVL,
Reimbursement
